Monster Digital Announces Offer to Amend and Exercise

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
64
Monster Digital Announces Offer to Amend and Exercise Warrants to Purchase Shares of Common Stock

SIMI VALLEY, CA--(Marketwired - Sep 25, 2017) - Monster Digital, Inc. ("Monster Digital" or the "Company") ( NASDAQ : MSDI ), announced that it has commenced an offer to amend certain warrants to purchase 4,421,676 shares of Monster Digital common stock originally issued by Monster Digital. Monster Digital is offering those holders of record as of September 19, 2017 (the " Record Date ") who are "accredited investors" as that term is defined in Rule 501(a) promulgated under the Securities Act of 1933, as amended (each an " Eligible Holder " and together the " Eligible Holders "), of outstanding warrants to purchase common stock of the Company the opportunity to amend and exercise their warrants at a temporarily reduced cash exercise price of $0.45 per share of common stock, upon the terms set forth in the Offer to Amend and Exercise Warrants to Purchase Common Stock dated as of September 22, 2017 (the " Offer to Amend and Exercise ").

The warrants subject to the Offer to Amend and Exercise are outstanding warrants as of the Record Date to purchase:

  • 2,025,000 shares of the Company's common stock at an exercise price of $5.625 per share issued to investors in the Company's initial public offering which closing occurred in July 2016 (the " IPO Warrants ");
  • 1,405,007 shares of the Company's common stock at an exercise price of $5.625 per share issued to holders of promissory notes, Series A Convertible Preferred stock and other indebtedness upon conversion of such indebtedness and preferred stock in connection with the Company's initial public offering which closing occurred in July 2016 (the " Conversion Warrants ");
  • 888,858 at an exercise price of $2.00 per share, issued to investors participating in and brokers assisting with certain of the Company's private placement financings which closings occurred from January 2017 to September 2017 (the " $2.00 Warrants ");
  • 64,668 issued to the placement agent and its assignees of the Company's private placement financings with respect to which closings occurred from October 2012 to January 2015 (35,547 at an exercise price of $14.85 per share and 29,121 an exercise price of $22.28 per share (together the " Placement Agent's Warrants "); and
  • 38,143 issued to the Company's public relations firm (6,004 in January 2017 at an exercise price of $5.00 per share, 7,230 in January 2017 at an exercise price of $7.00 per share, 9,986 in March 2017 at an exercise price of $9.00 per share and 14,923 in March 2017 at an exercise price of $11.00 per share) (together the " PR Warrants ").

The IPO Warrants, the Conversion Warrants, the $2.00 Warrants, the Placement Agent Warrants and the PR Warrants are known together as the " Original Warrants. "

As previously announced, on July 3, 2017, the Company entered into an Agreement and Plan of Merger (the " Merger Agreement ") by and among the Company, the Company's wholly owned subsidiary, Monster Merger Sub, Inc., a Delaware corporation (" Merger Sub "), and Innovate Biopharmaceuticals, Inc., a Delaware corporation (" Innovate "). Under the terms of the Merger Agreement, pending Company stockholder approval of the transaction, Merger Sub will merge into Innovate with Innovate surviving the merger and becoming a wholly-owned subsidiary of Monster (the " Merger "). On August 25, 2017, the Company filed a proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934 (the " Proxy Statement ") with respect to a special meeting of stockholders to take place on October 31, 2017 (the " Special Meeting ") to approve the Merger as well as other matters, including Proposal No. 6 therein whereby Company stockholders will vote at the Special Meeting to those matters set forth in the Offer to Amend and Exercise. The exercise of the Original Warrants further to the Offer to Amend and Exercise is expressly contingent on the approval of Proposal No. 6 by Company stockholders at the Special Meeting.

The purpose of the Offer to Amend and Exercise is to encourage the amendment and exercise of the Original Warrants by significantly reducing both the exercise price and the exercise period of the Original Warrants in order to provide funds to support the Company's operations.

All Original Warrants are eligible to be amended pursuant to the Offer to Amend. The Offer to Amend and Exercise is not conditioned upon a minimum number of Original Warrants being tendered. The Offer to Amend and Exercise is subject to certain customary conditions including the approval of Proposal No. 6 by Company stockholders at the Special Meeting as referenced above.

To participate in the Offer to Amend and Exercise and exercise an Amended Warrant to receive the number of shares of Company common stock issuable therefor, an Eligible Holder must deliver to the Company, prior to the Expiration Date, the following: (i) a signed and completed copy of the Election to Consent, Participate and Exercise Warrant,(ii) a signed copy of an Accredited Investor Questionnaire, (iii) the original copy of the Eligible Holder's Original Warrant, physically or, if he/she/it holds IPO Warrants, via DTC (or an Affidavit of Loss and Indemnification Agreement), for cancellation, and (iv) cash in the amount equal to $0.45 per share multiplied by the number of shares of common stock such Eligible Holder elects to purchase (collectively, the " Acceptance and Exercise Documents "). The Acceptance and Exercise Documents, including the cash tendered by check or wire transfer, must be delivered prior to the Expiration Date as set forth in the Offer to Amend and Exercise as described in the Schedule TO that was filed with the U.S. Securities and Exchange Commission (the " SEC ") and is being distributed to warrant holders.

None of the Company, its Board of Directors, officers or employees makes any recommendations to warrant holders as to whether to participate in the Offer to Amend and Exercise.

This press release is for informational purposes only and is not an offer to purchase or a solicitation of an offer to sell securities. The Offer to Amend and Exercise described above is made only pursuant to an Offer to Amend and Exercise on Schedule TO and related exhibits, including the related letter from David H. Clarke dated September 22, 2017, the Election to Consent, Participate and Exercise Warrant Form, the Withdrawal Form, the Accredited Investor Questionnaire, the Form of Amendment of the Original Warrants and other related documents, filed with the SEC. Warrant holders should read the Offer to Amend and Exercise on Schedule TO, the related letter from David H. Clarke dated September 22, 2017, the Election to Consent, Participate and Exercise Warrant Form, the Withdrawal Form, the Accredited Investor Questionnaire, the Form of Amendment of the Original Warrants and related exhibits, as they contain important information about the Offer to Amend and Exercise. Warrant holders can obtain these documents free of charge from the SEC's website at www.sec.gov , or by directing a request to the Company at 2655 First Street, Suite 250, Simi Valley, CA 93065, Attention: Chief Financial Officer, (805) 915-4775 .

About Monster Digital, Inc.

Monster Digital develops, markets and distributes Monster branded products for use in high-performance consumer electronics, mobile products and computing applications. The Company designs and engineers premium action sports cameras and accessories, in addition to advanced data storage and memory products for professionals and consumers.

Monster and Monster Digital are registered trademarks of Monster Products, Inc. in the U.S. and other countries.

For more information about the company, please visit http://www.monsterdigital.com

Forward-Looking Statements This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of the Company, are generally identified by use of words "anticipate," "believe," "estimate," "expect," "intend," "plan," "project," "seek," "strive," "try," or future or conditional verbs such as "could," "may," "should," "will," "would," or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, Monster Digital undertakes no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.

Contacts: Monster Digital, Inc. David Olert CFO dolert@monsterdigital.com Investor Relations: Monster Digital, Inc. Vivian Cervantes PCG Advisory 212-554-5482 vivian@pcgadvisory.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 5

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 5

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 4

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 4

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 4

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 7

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 5

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 5

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading

Top 5 Most Recently Viewed Articles

Leadership Changes at Church & Dwight: A New Era Begins

Updated Category News Views 364

Leadership Change at Church & Dwight Church & Dwight Co., Inc. (NYSE: CHD) is poised for an important change with the announcement of a leadership transition that will significantly impact the future of the company. The Board of Directors has confirmed that Richard Dierker, who has enjoyed a successful 15-year tenure with the company, will assume the role of President and...

Continue Reading
Artesian Resources Corporation Boosts Common Stock Dividend by 2%

Updated Category News Views 119

Artesian Resources Corporation Increases Dividend by 2% Artesian Resources Corporation (NASDAQ: ARTNA) recently announced an exciting update for its shareholders: a 2% increase in the quarterly common stock dividend. This decision was made by the Board of Directors and reflects the company's ongoing commitment to financial stability and shareholder satisfaction. The...

Continue Reading
Global Focus on Soil Health: The Second World Living Soils Forum

Updated Category News Views 147

World Living Soils Forum: A New Era for Soil Protection In a world increasingly focused on sustainability, the preservation and regeneration of our soils have become paramount. The second edition of the World Living Soils Forum is set to take place at LUMA Arles, aiming to unite visionaries and innovators dedicated to soil health. Making an Impact Together This...

Continue Reading
TNL Mediagene Achieves Market Recognition with Four Awards

Updated Category News Views 152

TNL Mediagene Achieves Market Recognition TNL Mediagene's remarkable performance in the recent awards showcases the strength and innovative spirit of its three companies. The Agency & Advertiser of the Year Awards 2024 highlighted their collective achievements, demonstrating a significant leadership position in news media, marketing technology, data services, and policy...

Continue Reading
Investors Boost Legal Action Against Lineage, Inc. Misrepresentation

Updated Category News Views 107

Investors Take Action Against Lineage, Inc. for IPO Misrepresentation Investors holding shares of Lineage, Inc. (NASDAQ: LINE) are now taking a united stand against the company, as substantial concerns arise regarding the integrity of its Initial Public Offering (IPO). Wolf Haldenstein Adler Freeman & Herz LLP is leading the charge in a class action lawsuit aimed at...

Continue Reading